Overview: Sidekick Health and Lilly Collaborate to Support Breast Cancer Patients, Alder Hey Children’s NHS FT Launches Homeless Hospital

Sidekick Health and Lilly are working together to support breast cancer patients

Initiation of digital therapy (DTx). Sidekick Health announced an integrated solution in relation to the pharmaceutical company Eli Lily and company for patients with breast cancer.

Through the Sidekick platform, patients will have access to a personalized digital treatment plan to promote behavior change and overcome barriers to change. Patients will also have access to educational content about living with cancer. The integrated DTx proposal will initially be launched in Germany in July.

Dr Tryggvi Thorgeirsson, CEO and co-founder, Sidekick, said: “At Sidekick, our goal is to enable patients to take real steps to better manage their disease and alleviate the negative side effects of treatment.”

Alder Hey Children’s NHS Foundation Trust launches “hospital without walls”

The Alder Hey Children’s NHS Foundation Trust has launched an interactive and immersive digital platform to create a “hospital without walls” for families, children, young people and clinicians to manage, treat, educate and coordinate the delivery of their healthcare.

IN AlderHey @ nywhere™ The platform was developed by Alder Hey Innovation in collaboration with Microsoft and health company Mindwave as a solution to address the limited capacity of hospital and public resources.

Managing Director, Alsha Hey innovationClaire Leedy said: “What we want to do is move to a more preventive model of care that is individualized and tailored and that enables children and young people to take responsibility for their health and treatment.

The Scandinavian pioneer in nursing technology will start in the United Kingdom

Norwegian VAR Healthcare, a provider of online knowledge and decision support systems for Scandinavian first-line staff, will launch in the United Kingdom.

The company is launching a pilot scheme with staff at the Leeds Teaching Hospitals NHS Trust with the support of Innovation Pop Up.

VAR Healthcare provides nurses and healthcare professionals with a digital tool to quickly access the details of hundreds of clinical procedures in support of safe and continuous patient care.

Ann Kristin Rotegård PhD, Managing Director, VAR Healthcares said: “We have the ambition to further disseminate and share best practices to support all nurses so that they can provide the best possible care for patients.”

The Swedish company HN is introducing a tool for the health care of the population with AI in the NHS

An artificial intelligence tool (AI) created by Sweden’s extended HN has proven that it can identify 83% of people who would otherwise need unplanned hospital care months in advance.

The tool, called HN Predict, has been tested on existing NHS Greater Glasgow & Clyde patient data and is being implemented in integrated care systems in Staffordshire, North Yorkshire, Scotland and the Republic of Ireland.

In a clinical trial, published in British general practice journalone of the four referrals to hospitals identified by the AI ​​can be prevented by supporting these high-risk patients with virtual ward support led by a nurse.

Dr Joachim Wer, founder and CEO of HN, said: “HN Predict works by applying machine learning to routinely collected healthcare data, making existing information a powerful resource for preventive healthcare.

Ibex receives CE mark for solution for detecting stomach cancer powered by artificial intelligence

Israel based startup Ibex Medical Analytics has announced the CE mark for Galen Gastric, a diagnostic solution that helps pathologists detect various types of stomach cancer.

The CE mark follows the results of a blinded, multifaceted clinical trial in the Medipath Pathology Network in France and the Maccabi Healthcare Services Health Network in Israel.

Galen Gastric demonstrates very high accuracy in detecting various types of stomach cancer, as well as Helicobacter pylori (H. pylori – a common gastric bacterial infection and cancer precursor), neuroendocrine lesions, dysplasia, adenoma and additional pathologies.

Judith Sandbank, MD, director of the Pathology Institute at Maccabi Healthcare Services, said: “We have already started using Galen Gastric in Maccabi and this has helped us improve the quality of cancer diagnosis and patient care.

Related Posts

Leave a Reply

Your email address will not be published.